Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT 24.02   2024 Perspectives for Biotechnology Companies   For many, if not for most biotechnology companies, 2023 has been a dreadful and frustrating year. Annus horribilis said the CEO of one of them, who had to restructure his organisation with […]

Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation jcm9144@gmail.com     SPECIAL REPORT     US FDA/CDER Novel Drug Approvals for 2023   According to the latest report from the US FDA’s Center for Drug Evaluation and Research (CDER), the health agency has approved 55 novel drugs in 2023. The comprehensive list of active ingredient […]